NO20064577L - Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander - Google Patents

Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander

Info

Publication number: NO20064577L
Authority: NO; Norway
Prior art keywords: tetrahydronaphthindine; histamine; receptor ligands; derivatives useful; derivatives
Prior art date: 2004-05-12

Application number

NO20064577A

Other languages

English (en)

Norwegian (no)

Inventor

John Paul Mathias

Graham Lunn

Ross Sinclair Strang

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2006-10-09

Publication date

2006-11-06

2006-10-09 Application filed by Pfizer filed Critical Pfizer

2006-11-06 Publication of NO20064577L publication Critical patent/NO20064577L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Otolaryngology (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Immunology (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)

NO20064577A 2004-05-12 2006-10-09 Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander NO20064577L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04291222A EP1595881A1 (en)	2004-05-12	2004-05-12	Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
PCT/IB2005/001267 WO2005111036A1 (en)	2004-05-12	2005-05-06	Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands

Publications (1)

Publication Number	Publication Date
NO20064577L true NO20064577L (no)	2006-11-06

Family

ID=34931096

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064577A NO20064577L (no)	2004-05-12	2006-10-09	Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander

Country Status (32)

Country	Link
US (2)	US7557121B2 (es)
EP (2)	EP1595881A1 (es)
JP (1)	JP4084410B2 (es)
KR (1)	KR100908155B1 (es)
CN (2)	CN1950371B (es)
AP (1)	AP2006003786A0 (es)
AR (1)	AR049092A1 (es)
AT (1)	ATE491707T1 (es)
AU (1)	AU2005243403B2 (es)
BR (1)	BRPI0510762A (es)
CA (1)	CA2564201C (es)
CR (1)	CR8747A (es)
DE (1)	DE602005025345D1 (es)
DK (1)	DK1756104T3 (es)
EA (1)	EA010487B1 (es)
EC (1)	ECSP066984A (es)
ES (1)	ES2355572T3 (es)
GE (1)	GEP20084552B (es)
GT (1)	GT200500112A (es)
IL (1)	IL178882A (es)
MA (1)	MA28579B1 (es)
MX (1)	MXPA06013113A (es)
NL (1)	NL1029016C2 (es)
NO (1)	NO20064577L (es)
PA (1)	PA8632801A1 (es)
PE (1)	PE20060312A1 (es)
SV (1)	SV2005002112A (es)
TN (1)	TNSN06369A1 (es)
TW (1)	TW200607506A (es)
UY (1)	UY28895A1 (es)
WO (1)	WO2005111036A1 (es)
ZA (1)	ZA200609111B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6468306B1 (en)	1998-05-29	2002-10-22	Advanced Medical Optics, Inc	IOL for inhibiting cell growth and reducing glare
BRPI0417503B1 (pt)	2003-12-09	2015-07-21	Abbott Medical Optics Inc	Lente intra-ocular dobrável
AU2006261162A1 (en) *	2005-06-17	2006-12-28	Janssen Pharmaceutica N.V.	Naphthyridine compounds
US8158673B2 (en) *	2005-10-27	2012-04-17	Pfizer Inc.	Histamine-3 receptor antagonists
JP2009514846A (ja) *	2005-11-04	2009-04-09	ファイザー・リミテッド	テトラヒドロナフチリジン誘導体
WO2007099423A1 (en) *	2006-03-02	2007-09-07	Pfizer Products Inc.	1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
KR20080109841A (ko)	2006-03-10	2008-12-17	뉴로젠 코포레이션	피페라지닐 옥소알킬 테트라히드로이소퀴놀린 및 관련유사체
BRPI0712823A2 (pt)	2006-06-23	2012-07-24	Abbott Lab	derivados de ciclopropil amina como moduladores de receptor de histamina h3
US9108948B2 (en)	2006-06-23	2015-08-18	Abbvie Inc.	Cyclopropyl amine derivatives
JP5520051B2 (ja) *	2007-11-15	2014-06-11	武田薬品工業株式会社	縮合ピリジン誘導体およびその用途
US8383657B2 (en)	2007-12-21	2013-02-26	Abbott Laboratories	Thiazolylidine urea and amide derivatives and methods of use thereof
WO2009082698A1 (en) *	2007-12-21	2009-07-02	Abbott Laboratories	Compositions for treatment of cognitive disorders
CA2716330A1 (en) *	2008-02-22	2009-08-27	Irm Llc	Compounds and compositions as modulators of gpr119 activity
EP2268638A1 (en) *	2008-03-31	2011-01-05	Evotec AG	Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
WO2010026113A1 (en) *	2008-09-03	2010-03-11	Evotec Neurosciences Gmbh	Acyl- and sufonyl tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists
WO2010052222A1 (en) *	2008-11-07	2010-05-14	Evotec Neurosciences Gmbh	(dihydro)naphthyridinone derivatives as histamine h3 receptor antagonists
EP2421863A1 (en) *	2009-04-21	2012-02-29	NeuroSearch AS	Substituted naphthyridine derivatives and their medical use
US9186353B2 (en)	2009-04-27	2015-11-17	Abbvie Inc.	Treatment of osteoarthritis pain
US8711772B2 (en) *	2009-05-22	2014-04-29	Qualcomm Incorporated	Paging of a user equipment (UE) within a wireless communications system
US20120101106A1 (en) *	2009-07-09	2012-04-26	Mercer Swati P	Tetrahydronapthyridine Orexin Receptor Antagonists
US8853390B2 (en)	2010-09-16	2014-10-07	Abbvie Inc.	Processes for preparing 1,2-substituted cyclopropyl derivatives
CN102093356B (zh) *	2011-03-16	2012-12-19	无锡美克赛医药科技有限公司	一种2-氯-5,6,7,8-四氢-1,6-萘啶盐酸盐的制备方法
WO2012131539A1 (en)	2011-03-31	2012-10-04	Pfizer Inc.	Novel bicyclic pyridinones
WO2012172449A1 (en)	2011-06-13	2012-12-20	Pfizer Inc.	Lactams as beta secretase inhibitors
EP2751116B1 (en)	2011-08-31	2016-10-12	Pfizer Inc	Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
ES2585262T3 (es)	2012-05-04	2016-10-04	Pfizer Inc	Compuestos heterocíclicos de hexahidropiran[3,4-d][1,3]tiazin-2-amina sustituidos como inhibidores de PPA, BACE1 y BACE2
EP2867236B1 (en)	2012-06-29	2017-06-14	Pfizer Inc	Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
JP2015529239A (ja)	2012-09-20	2015-10-05	ファイザー・インク	アルキル置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
UA110688C2 (uk)	2012-09-21	2016-01-25	Пфайзер Інк.	Біциклічні піридинони
CA2893256A1 (en)	2012-12-11	2014-06-19	Pfizer Inc.	Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
EP2935282A1 (en)	2012-12-19	2015-10-28	Pfizer Inc.	CARBOCYCLIC- AND HETEROCYCLIC-SUBSTITUTED HEXAHYDROPYRANO[3,4-d][1,3]THIAZIN-2-AMINE COMPOUNDS
JP2016507551A (ja)	2013-02-13	2016-03-10	ファイザー・インク	ヘテロアリール置換ヘキサヒドロピラノ［３，４−ｄ］［１，３］チアジン−２−アミン化合物
US9233981B1 (en)	2013-02-15	2016-01-12	Pfizer Inc.	Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
MD20150071A2 (ro)	2013-02-19	2016-02-29	Pfizer Inc.	Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni
ES2637816T3 (es)	2013-05-02	2017-10-17	Pfizer Inc.	Derivados de imidazo-triazina como inhibidores de PDE10
WO2015049616A1 (en)	2013-10-04	2015-04-09	Pfizer Inc.	Novel bicyclic pyridinones as gamma-secretase modulators
WO2015092592A1 (en)	2013-12-17	2015-06-25	Pfizer Inc.	Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
AP2016009465A0 (en)	2014-04-01	2016-09-30	Pfizer	Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators
KR20180078347A (ko)	2014-04-10	2018-07-09	화이자 인코포레이티드	2-아미노-6-메틸-4,4a,5,6-테트라히드로피라노[3,4-d][1,3]티아진-8a(8H)-일-1,3-티아졸-4-일 아미드
US10131669B2 (en)	2014-07-24	2018-11-20	Pfizer Inc.	Pyrazolopyrimidine compounds
HUE044040T2 (hu)	2014-08-06	2019-09-30	Pfizer	Imidazopiridazin vegyületek
EP3253755B1 (en)	2015-02-03	2020-08-26	Pfizer Inc	Novel cyclopropabenzofuranyl pyridopyrazinediones
SMT201900587T1 (it) *	2015-05-28	2019-11-13	Theravance Biopharma R&D Ip Llc	Composti di naftiridina come inibitori di chinasi jak
TN2017000485A1 (en)	2015-06-17	2019-04-12	Pfizer	Tricyclic compounds and their use as phosphodiesterase inhibitors
KR102161364B1 (ko)	2015-09-14	2020-09-29	화이자 인코포레이티드	LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체
JP2018531923A (ja)	2015-09-24	2018-11-01	ファイザー・インク	Ｎ−［２−（２−アミノ−６，６−二置換−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル）−１，３−チアゾール−４−イル］アミド
EP3353182A1 (en)	2015-09-24	2018-08-01	Pfizer Inc	Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
JP2018534251A (ja)	2015-09-24	2018-11-22	ファイザー・インク	Ｂａｃｅ阻害剤として有用なｎ−［２−（３−アミノ−２，５−ジメチル−１，１−ジオキシド−５，６−ジヒドロ−２ｈ−１，２，４−チアジアジン−５−イル）−１，３−チアゾール−４−イル］アミド
AU2017223132B2 (en)	2016-02-23	2019-12-05	Pfizer Inc.	6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
HUE054857T2 (hu)	2016-07-01	2021-10-28	Pfizer	5,7-dihidro-pirrolo-piridinszármazékok neurológiai és neurodegeneratív betegségek kezelésére
MX2019010756A (es)	2017-03-10	2020-01-20	Pfizer	Derivados novedosos de imidazo[4,5-c]quinolina como inhibidores de cinasa 2 rica en repetición de leucina (lrrk2).
US11161844B2 (en)	2017-03-10	2021-11-02	Pfizer Inc.	Cyclic substituted imidazo[4,5-c]quinoline derivatives
WO2018226992A1 (en)	2017-06-07	2018-12-13	Adrx, Inc.	Tau aggregation inhibitors
US11198692B2 (en)	2017-06-22	2021-12-14	Pfizer Inc.	Dihydro-pyrrolo-pyridine derivatives
AU2018318319A1 (en)	2017-08-18	2020-02-20	Adrx, Inc.	Tau aggregation peptide inhibitors
WO2019183636A1 (en)	2018-03-23	2019-09-26	Pfizer Inc.	Piperazine azaspiro derivaves
US12144815B2 (en)	2021-02-23	2024-11-19	Hoth Therapeutics, Inc.	Use of aprepitant for treating Alzheimer's disease
TWI835144B (zh) *	2021-05-21	2024-03-11	大陸商成都百裕製藥股份有限公司	哌嗪衍生物及其在醫藥上的應用
WO2025145091A1 (en)	2023-12-29	2025-07-03	Pfizer Inc.	Crystalline forms of a muscarinic m4 receptor modulator and methods of treating diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
RU2182904C2 (ru)	1996-02-09	2002-05-27	Джеймс Блэк Фаундейшн Лимитед	Сульфонамиды и способы их получения
WO2000035298A1 (en)	1996-11-27	2000-06-22	Wm. Wrigley Jr. Company	Chewing gum containing medicament active agents
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
GB9803536D0 (en) *	1998-02-19	1998-04-15	Black James Foundation	Histamine H,receptor ligands
EP0982300A3 (en)	1998-07-29	2000-03-08	Societe Civile Bioprojet	Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
TWI298068B (en) *	2000-06-21	2008-06-21	Dainippon Sumitomo Pharma Co	Pharmaceutical composition for schizophrenia
PT1301480E (pt)	2000-07-13	2007-11-29	Abbott Lab	Pirrolidinas 1,3-di-substituídas e 1,3,3-tri-substituídas úteis como ligandos do receptor de histamina-3 e suas aplicações terapêuticas
DK1313721T3 (da) *	2000-08-08	2006-06-26	Ortho Mcneil Pharm Inc	Ikke-imidazol-aryloxyalkylaminer som H3-receptorligander
HUP0302893A3 (en)	2000-08-08	2006-04-28	Ortho Mcneil Pharm Inc	Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
WO2002076925A2 (en)	2001-03-23	2002-10-03	Eli Lilly And Company	Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
GB0206033D0 (en) *	2002-03-14	2002-04-24	Pfizer Ltd	Compounds useful in therapy
DK1651615T3 (da) *	2003-07-29	2010-05-25	High Point Pharmaceuticals Llc	Pyridazinyl-piperaziner og anvendelse deraf som histamin-H3-receptorligander
JP2009514846A (ja) *	2005-11-04	2009-04-09	ファイザー・リミテッド	テトラヒドロナフチリジン誘導体

2004
- 2004-05-12 EP EP04291222A patent/EP1595881A1/en not_active Withdrawn
2005
- 2005-05-06 MX MXPA06013113A patent/MXPA06013113A/es active IP Right Grant
- 2005-05-06 WO PCT/IB2005/001267 patent/WO2005111036A1/en not_active Ceased
- 2005-05-06 AP AP2006003786A patent/AP2006003786A0/xx unknown
- 2005-05-06 EP EP05736116A patent/EP1756104B1/en not_active Expired - Lifetime
- 2005-05-06 CN CN2005800150008A patent/CN1950371B/zh not_active Expired - Fee Related
- 2005-05-06 AU AU2005243403A patent/AU2005243403B2/en not_active Ceased
- 2005-05-06 AT AT05736116T patent/ATE491707T1/de not_active IP Right Cessation
- 2005-05-06 ES ES05736116T patent/ES2355572T3/es not_active Expired - Lifetime
- 2005-05-06 EA EA200601897A patent/EA010487B1/ru not_active IP Right Cessation
- 2005-05-06 KR KR1020067023573A patent/KR100908155B1/ko not_active Expired - Fee Related
- 2005-05-06 CA CA2564201A patent/CA2564201C/en not_active Expired - Fee Related
- 2005-05-06 DE DE602005025345T patent/DE602005025345D1/de not_active Expired - Lifetime
- 2005-05-06 GE GEAP20059701A patent/GEP20084552B/en unknown
- 2005-05-06 JP JP2007512575A patent/JP4084410B2/ja not_active Expired - Fee Related
- 2005-05-06 BR BRPI0510762-8A patent/BRPI0510762A/pt not_active IP Right Cessation
- 2005-05-06 CN CN201010150783A patent/CN101798305A/zh active Pending
- 2005-05-06 DK DK05736116.4T patent/DK1756104T3/da active
- 2005-05-11 NL NL1029016A patent/NL1029016C2/nl not_active IP Right Cessation
- 2005-05-11 TW TW094115276A patent/TW200607506A/zh unknown
- 2005-05-11 AR ARP050101916A patent/AR049092A1/es unknown
- 2005-05-12 PA PA20058632801A patent/PA8632801A1/es unknown
- 2005-05-12 PE PE2005000533A patent/PE20060312A1/es not_active Application Discontinuation
- 2005-05-12 UY UY28895A patent/UY28895A1/es not_active Application Discontinuation
- 2005-05-12 SV SV2005002112A patent/SV2005002112A/es not_active Application Discontinuation
- 2005-05-12 US US11/128,804 patent/US7557121B2/en not_active Expired - Fee Related
- 2005-05-12 GT GT200500112A patent/GT200500112A/es unknown
2006
- 2006-10-09 NO NO20064577A patent/NO20064577L/no not_active Application Discontinuation
- 2006-10-26 IL IL178882A patent/IL178882A/en not_active IP Right Cessation
- 2006-11-01 ZA ZA200609111A patent/ZA200609111B/xx unknown
- 2006-11-09 EC EC2006006984A patent/ECSP066984A/es unknown
- 2006-11-10 MA MA29447A patent/MA28579B1/fr unknown
- 2006-11-10 CR CR8747A patent/CR8747A/es unknown
- 2006-11-10 TN TNP2006000369A patent/TNSN06369A1/fr unknown
2009
- 2009-06-25 US US12/491,370 patent/US20090258861A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PA8632801A1 (es)	2006-06-02
PE20060312A1 (es)	2006-05-03
GT200500112A (es)	2005-12-12
TW200607506A (en)	2006-03-01
NL1029016A1 (nl)	2005-11-15
GEP20084552B (en)	2008-11-25
CA2564201A1 (en)	2005-11-24
CN1950371B (zh)	2011-01-12
KR100908155B1 (ko)	2009-07-16
EP1756104A1 (en)	2007-02-28
CN101798305A (zh)	2010-08-11
BRPI0510762A (pt)	2007-11-20
NL1029016C2 (nl)	2006-05-30
EP1595881A1 (en)	2005-11-16
US20090258861A1 (en)	2009-10-15
UY28895A1 (es)	2005-12-30
CR8747A (es)	2006-12-05
AU2005243403B2 (en)	2010-10-07
IL178882A0 (en)	2007-03-08
CN1950371A (zh)	2007-04-18
JP4084410B2 (ja)	2008-04-30
WO2005111036A1 (en)	2005-11-24
CA2564201C (en)	2011-01-18
EP1756104B1 (en)	2010-12-15
ECSP066984A (es)	2006-12-29
EA200601897A1 (ru)	2007-02-27
DK1756104T3 (da)	2011-02-21
IL178882A (en)	2011-03-31
ZA200609111B (en)	2008-08-27
ES2355572T3 (es)	2011-03-29
AU2005243403A1 (en)	2005-11-24
JP2007536374A (ja)	2007-12-13
SV2005002112A (es)	2005-12-13
AP2006003786A0 (en)	2006-10-31
EA010487B1 (ru)	2008-10-30
MA28579B1 (fr)	2007-05-02
AR049092A1 (es)	2006-06-28
KR20070014174A (ko)	2007-01-31
ATE491707T1 (de)	2011-01-15
TNSN06369A1 (fr)	2008-02-22
US20050256135A1 (en)	2005-11-17
DE602005025345D1 (de)	2011-01-27
MXPA06013113A (es)	2007-02-28
US7557121B2 (en)	2009-07-07

Publication	Publication Date	Title
NO20064577L (no)	2006-11-06	Tetrahydronaftyndin-derivater nyttige som histamin H3 reseptorligander
NO20066055L (no)	2007-01-24	Pyridinderivater
NO20084005L (no)	2008-09-19	Aminderivater
NO20050828L (no)	2005-04-05	lndol-3-svovelderivater
NO20062983L (no)	2006-07-24	Sulfonamid-derivater for behandling av sykdommer
NO20063761L (no)	2006-10-23	Sulfonamidderivater for behandling av sykdommer
NO20060774L (no)	2006-04-06	Kinolin- og kinazolinderivater som har affinitet for 5HT1-typereseptorer
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
NO20075624L (no)	2007-11-28	Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
NO20070249L (no)	2007-02-15	Pyrrazolo-pyrimidin derivater
NO20080408L (no)	2008-03-25	Azaindazolforbindelser og anvendelse derav
ATE479686T1 (de)	2010-09-15	Pyridopyrrolizin- und pyridoindolizinderivate
DE60237528D1 (de)	2010-10-14	Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
NO20071140L (no)	2007-04-19	Nye piperidinderivater som histamin H3 reseptorligander for behandling av depresjon
TW200505862A (en)	2005-02-16	2-amino-pyridine derivatives useful for the treatment of diseases
NO20062020L (no)	2006-07-10	1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20055854L (no)	2006-02-10	(2-hyroksy-2-(4-hydroksy-3-hydroksymetylfenyl)--etylamino)-propylfenylderivater som beta2 agonister
WO2005060959A8 (en)	2006-01-12	Pyrazole derivatives and use thereof as orexin receptor antagonists
NO20070564L (no)	2007-03-15	Kinoliner uten tiazolinonsubstituenter.
NO20082214L (no)	2008-07-31	1,1-Diokso-tiomorfolinyl-indolyl-metanonderivater for anvendelse som H3-modulatorer
NO20065327L (no)	2006-12-18	Fremgangsmate for fremstilling av derivarer av 5-'4-(2-hydroksy-propyl)-3,5-dihydro-3H'1, 2,4(triazin-2-yl)-benzamid.
EA200601462A1 (ru)	2007-04-27	Соединения для лечения заболеваний
NO20062491L (no)	2006-09-06	Benzoksazinderivter og deres anvendelse
DE50311923D1 (de)	2009-10-29	Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel
NO20080669L (no)	2008-05-15	Acetylenpiperaziner som metabotrofiske glutamatreseptorantagonister

Legal Events

Date	Code	Title	Description
2012-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application